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Abstract 
Purpose: To systematically review the literature to determine 1) the diagnostic and 2) 
treatment prevalence of attention deficit hyperactivity disorder among African American 
youth and compare the prevalence to Caucasian children and adolescents. 
Methods: Medline, Psychinfo, and Web of Science databases were searched from 1994-
present for cross-sectional studies, cohort, non-randomized clinical trials, and meta-
analyses that contained information regarding the diagnostic prevalence or prevalence of 
treatment for ADHD and compared African-Americans children and/or adolescents with 
Caucasian children and/or adolescents,. The author independently assessed studies for 
inclusion and quality. 
Results: 10 studies met inclusion and quality criteria for diagnosis and/or treatment and 
thus received detailed evaluation. Four studies specifically compared prevalence of an 
ADHD diagnosis between African-Americans and Caucasians while 9 studies specifically 
addressed treatment rates for ADHD among different ethnic subgroups. Three of the four 
(7 5%) of the articles examining diagnostic prevalence demonstrated there was no 
significant difference in the likelihood of being diagnosed with ADHD between Caucasian 
American and African-Americans children. Of the articles examining treatment 
prevalence, seven of the nine (71.4%) articles demonstrated African-Americans were less 
likely than Caucasian Americans to receive ADHD medications. Of note, other disparities 
in diagnosis and treatment of ADHD such as regional and health insurance factors were 
noted. 
Conclusions: Overall, it appears that disparities do exist in regards to ADHD treatment but 
not in diagnosis between African American and Caucasian youth. In addition to the need 
for higher quality, population-based studies that examine the disparate relationship 
between ADHD recognition and treatment in African American youth, further research 
should be dedicated to examining the factors that affect ADHD treatment rates in this 
group. Parental views and differential response to subtypes of ADHD treatment may play 
roles in this disparity. 
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Introduction 
Attention Deficit Hyperactivity Disorder (ADHD) is a neurobehavioral disorder 
characterized by six or more symptoms of inattentiveness or hyperactivity-impulsivity that 
have persisted for six months or more and that interfere with daily functioning (see Figure 
1). 1 It is among the most common psychiatric diagnoses of childhood in the United States 
and affects over two million children nationwide, or 3-5% of the population under 18 years 
of age.2'3 While it is estimated that African-Americans exhibit the same prevalence of 
ADHD as the Caucasian population3, the true prevalence rate of ADHD among African-
Americans is largely unknown due to lack of research aimed at group. 4•5 
Deficits in research may lead to disparities in recognition and treatment of ADHD 
in the African-American population. Studies have shown that cultural factors influence the 
manifestation of ADHD in ethnic groups differently than in Euro-American groups, and 
thus research conducted primarily in Euro-American groups may not be generalizable to 
other ethnic groups.6 Furthermore, lack of evidence of the true prevalence of ADHD in the 
African-American community may lead to over- or under-diagnosis of ADHD by medical 
professionals and teachers. Therefore it is imperative to identify whether or not disparities 
truly exist by examining the prevalence of ADHD diagnosis and treatment among African-
American youth compared with Caucasian youth. 
Several barriers exist that can lead to potential misdiagnosis (i.e. over-diagnosis or 
under- diagnosis) and treatment of ADHD in African-American youth, and thus a 
misrepresentation of the true prevalence in this population. These include factors involving 
parents, health care providers, the healthcare system, teachers, and the education system. 
Socioeconomic factors may also play a role in possible misrepresentation of ADHD in the 
African-American community (Figure 2).8 
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Figure 1. DSM IV Criteria for Attention Deficit Hyperactivity Disorder 
Either (1) or (2) 
(1). 6 (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree that 
is maladaptive and inconsistent with developmental level: 
Inattention 
(a) often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other 
activities 
(b) often has difficulty sustaining attention in tasks or play activities 
(c) often does not seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (not due to oppositional behavior or failure to understand 
instructions) 
(e) often has difficulty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as 
schoolwork or homework). 
(g) often loses things necessary for tasks or activities (e.g. toys, school assignments, pencils, books, or tools) 
(h) is often easily distracted by extraneous stimuli 
(i) is often forgetful in daily activities 
(2) 6 (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least 6 months to a 
degree that is maladaptive and inconsistent with developmental level 
Hyperactivity 
(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or in other situations in which remaining seated is expected 
(c) often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, 
may be limited to subjective feelings of restlessness) 
(d) often has difficulty playing or engaging in leisure activities quietly 
(e) is often "on the go" or often acts as if "driven by a motor" 
(f) often talks excessively 
Impulsivity 
(g) often blurts out answers before questions have been completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e.g. butts into conversations or games) 
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were present before age 7 
years. 
C. Some impairment from the symptoms is present in two or more settings (e.g. at school [or work] and at 
home). 
D. There must be clear evidence of clinically significant impairment in social, academic, or occupational 
functioning. 
E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder, 
Schizophrenia, or other Psychotic Disorder and are not better accounted for by another mental disorder (e.g. 
Mood Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder) 
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Potential Barriers to Diagnosis of ADHD in African-American Youth 
Parent level factors 
Health behavior, including demand for health services, is believed to be influenced 
by knowledge and beliefs held by individuals and their communities.2 Lack of knowledge 
of ADHD, including its characteristics, etiology, how it is diagnosed, and treatment 
options are factors that prevent parents of all ethnic and racial backgrounds from seeking 
help for their children with ADHD. However, this ignorance of ADHD seems to affect 
African-American parents to a larger extent than their Caucasian counterparts. In a study 
by Bussing eta!, a sample of 486 parents (224 African-American parents and 262 white 
parents) of 2nd_4th graders at high-risk for ADHD were surveyed by telephone and 
subsequently participated in face-to-face interviews to examine their knowledge of ADHD. 
Although most parents (83%) reported having previously heard about ADHD, parental 
self-rated knowledge about ADHD varied considerably: 24% said they knew a lot, 30% 
said they knew some, 32% said they knew a little, and 14% said they knew nothing about 
ADHD. When the results were analyzed according to race, only 69% of African Americans 
had ever heard about ADHD compared to 95% of Caucasian parents (p<O.OOl) and fewer 
estimated that they knew some or a lot about ADHD (36% vs. 70%, p= <0.001).2 
Another parental barrier that may influence help-seeking for their children with 
ADHD lies in understanding the etiology of ADHD. The belief that inattention and 
hyperactivity/impulsivity symptoms are solely due to behavioral problems and not a 
medical condition may prevent parents from having the condition diagnosed by medical 
professionals. 11 For instance, an interpretation of ADHD symptoms as a temporary 
adjustment phenomenon due to normal growth and development may lead parents to 
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believe that professional interventions are unnecessary. 10 Differences in African-American 
parental beliefs of causation of ADHD compared to Caucasian parents' beliefs may play a 
role in the discordance in help seeking for ADHD behaviors. According to Bussing and 
colleagues, when assessing parental beliefs of the origins of ADHD, significant differences 
were apparent between African American and Caucasian parents. This was especially true 
with regards to attributing ADHD to dietary sugar, genetics, and inherent shortcomings of 
their child.2 While more than 40% of caregivers overall incorrectly assumed excess dietary 
sugar to be the causal mechanism behind ADHD, twice as many African-American parents 
(59%) as Caucasian parents (30%) believed this to be true. A mere 10% of African-
American parents were definitely sure that sugar was not the cause of.ADHD compared to 
37% of Caucasian parents.2 Bussing eta! also found that African-American parents were 
less likely to attribute genetics as a cause of ADHD (75% vs. 91%, Fisher's exact=0.017) 
and were less likely to use medical labels to refer to the disorder (25% vs. 62%, Fisher's 
exact=O.OOO). The authors postulate that "disregarding the mainstream medical notion of 
ADHD may result in a lack of exchange about the disease within African American 
communities," leading to a vicious cycle of misinformation about the disorder in this 
. 2 
commumty. 
The social stigma associated with a diagnosis of ADHD may also serve as a barrier 
for African-American parents to seek help for their children with symptoms of ADHD. In 
a market research poll conducted by Harris Interactive, 41% of African-Americans parents 
surveyed believed African-American children are more likely "mislabeled" as having 
ADHD compared to other children whereas only 13% of Caucasian parents believed 
Caucasian children were more likely to be "mislabeled." Fifty-seven percent of African-
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American parents cited fear of stigmatization as a major reason for not seeking diagnosis 
and treatment of ADHD. 12 
Health Care Provider Factors 
Difficulties in standardizing a diagnostic tool for attention deficit hyperactivity 
disorder create a potential for cultural differences among ethnic and racial groups to 
influence the rate of diagnosis of ADHD. Bauermeister et al noted that both ADHD as a 
disorder and the instruments designed to assess it were derived from the perspective of 
Western professionals, using Western concepts of disorder and measurements, and without 
regard to cultural difference. In fact, studies have shown that behavior rating scales, one of 
the most common means of diagnosing ADHD, are not reliable across all ethnic groups. 9 
A review of recognition of psychosocial problems in outpatient and ambulatory 
care settings conducted by Kelleher et al found that African-American children were 
identified less often as having behavioral problems by pediatricians. 13 The reasons behind 
this may be many fold. Fear of causing additional problems via labeling of children may be 
a contributing factor to under-diagnosis of ADHD by physicians. In a qualitative study 
conducted in Great Britain involving families of children with ADHD and their physicians, 
Klasen and colleagues found that physicians were often reluctant to diagnose or medicalize 
a child's inattentive and or hyperactive-impulsive behavior as ADHD because of the 
stigma attached to it. 9 Another factor may be preconceived notions and stereotypes of 
African-American behavior. According to Bailey et al, a common misperception of 
African-American children is that they are more active than their peers from other 
backgrounds.8 
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Teacher/Education System Factors 
Since a large percentage of newly diagnosed ADHD cases are a result of 
teacher/educator referral, examining factors that may influence differences in reporting 
African-American and Caucasian students is essential. Similar to healthcare provider 
biases, teachers may have their own conscious or subconscious stereotypes of African-
American youth that may potentiate misdiagnosis of ADHD. In a study examining teacher 
reports of DSM-IV ADHD, oppositional defiant disorder, and conduct disorder symptoms 
in schoolchildren, Nolan et a! found teachers rated a larger percentage of African-
American students as having ADHD as compared to Caucasian students (39.5% vs. 14.2%) 
and that this finding was consistent with previous studies. 14 The authors note that in some 
cases teachers may have confused ADHD behaviors with other problems (e.g., low IQ, 
anxiety, psychosocial stressors). 
Also similar to health care providers, problems with assessing cultural factors in 
behavioral rating scales may play a role in this seemingly over-diagnosis of African 
Americans students by their teachers. DuPaul et a! assessed the factorial structure and 
normative data of a teacher rating scale containing the 18 symptoms of ADHD and found 
that teachers rated African American students significantly more hyperactive than 
Caucasian students and scored them higher on both the hyperactivity-impulsivity and 
inattention factors across all age ranges represented in this national sample. However, the 
authors recommend exercising caution in interpreting these results as validity of the 
structure of the test for each of the ethnic groups represented in the United States needs to 
be demonstrated.16 Similarly, in a study utilizing a behavior rating scale to identify ADHD 
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in Caucasian and African-American males, Reid et al found that although teachers rated 
African American students higher on all symptoms across all age groups, further analysis 
indicated the scale did not perform identically across all groups.7 
Socioeconomic Factors 
As encountered in other health care disparities, socioeconomic factors may play a 
role in the proposed discrepancy in ADHD diagnosis between African-American and 
Caucasian youth. Knowledge about ADHD tends to be less apparent in families from low 
socioeconomic backgrounds compared to those from middle and high-economic 
backgrounds. Poorer families often have limited access to medical care and as a result 
underutilize health care services. Furthermore, low SES has been implicated as a risk 
factor for ADHD. 18 
Potential Barriers to Treatment of ADHD in African-American Youth 
According to Children and Adults with Attention Deficit/Hyperactivity Disorder 
(CHADD), Caucasians are three times more likely to be referred for treatment of ADHD 
compared to African Americans. In the few studies exploring medication rates across 
races, ethnic minority children are 2 to 2.5 times less likely to be medicated than their 
Caucasian counterparts.19 Factors at the parental level, health care system level, education 
system, and the media may present barriers to treatment in African-American youth as 
well. 
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Parent level factors 
Aside from the factors that present barriers to diagnosis of ADHD previously 
described, some African-American parents may not see their child's ADHD as a large 
problem and thus may not be receptive to receiving treatment services for their children. 
Bussing et a!. conducted a two-phase study in which they attempted to examine 
explanatory models of ADHD and model variation according to child characteristics. 
Interviews were conducted with parents of 182 elementary school children to gather 
information regarding their views on labeling and etiology of ADHD as well as their ideas 
of the severity of symptoms in their child, the time course for the disorder, treatment 
options, concerns and desired outcomes for their child's condition. The study investigators 
found that African-America parents voiced less concerns over academic performance than 
Caucasian parents (OR 0.41, 95% CI 0.19-0.91), and were less likely to request medication 
treatment (OR 0.26, 95% CI 0.1-0.6) or school interventions (OR 0.39, 95% CI 0.15-1.0). 
In general, parents of children not receiving treatment were less likely to voice 
emotional/behavioral concerns than parents of children receiving treatment (OR 0.34, 95% 
CI 0.17-0.70). 11 
Another barrier to parents seeking treatment of their child's ADHD is intra-cultural 
issues of mistrust between African-Americans and the medical community. Bussing et a!. 
postulates that because of the long history of inequitable medical treatment and abuse (e.g., 
Tuskegee experiment), African American parents may feel concerns over treatment options 
for ADHD not for lack of knowledge about its effectiveness, but because they "may not 
view medical professionals as trustworthy allies."2 
10 
Impact of Misdiagnosis and Treatment of ADHD 
Unrecognized and untreated attention deficit hyperactivity disorder can lead to 
several long-term health and behavioral consequences. Untreated ADHD often hinders a 
child's ability to function and participate in school and social functions, putting them at 
greater risk for learning difficulties than children treated for ADHD.Z· 20 Symptoms of 
ADHD have been associated with lower IQ and poorer academic performance than their 
non-ADHD counterparts.22 Research shows that adults with untreated childhood ADHD 
are more than twice as likely to be arrested, twice as likely to get divorced, and twice as 
likely to hold 6 or more jobs in a 10-year period.21 
Attention deficit hyperactivity disorder is associated with comorbid psychiatric 
conditions such as depression, bipolar disorder, sleep problems, and phobias.21 These 
conditions are often exaggerated in children with unaddressed and/or untreated ADHD. In 
a study conducted by Abramowitz eta!, 275 Caucasian and male inmates were interviewed 
and surveyed for evidence of childhood conduct problems and ADHD. The investigators 
found that although to a much smaller degree than conduct problems, childhood ADHD 
conferred a significant additional risk for the antisocial lifestyles aspects of 
psychopathology seen in male prison inmates.22 A similar study conducted by Rabiner et 
al23 sought to identify the predictors of aggressive offending persisting from adolescence 
into young adulthood in a sample of 622 African American male offenders over a six-year 
period. They found that higher rates of ADHD symptoms predict the persistence of 
aggressive offending into young adulthood.23 
There are other less legally serious comorbidities associated with ADHD that affect 
physical health and quality of life. Klassen eta! used health-related quality-of-life (HRQL) 
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questionnaires, which are designed to gather information across a range of health domains, 
to determine quality of life across physical and psychosocial domains in a clinic-based 
sample of 131 children who had a diagnosis of ADHD. Physical functioning (PF), 
role/social limitations as a result of physical health (RP), bodily pain/discomfort (BP), and 
general health perception (GH) were the physical health domains evaluated using the 50-
item parent version of the Child Health Questionnaire. Psychosocial domains included the 
following: role/social limitations as a result of emotional-behavioral problems (REB), self-
esteem (SE), mental health (MH), general behavior (BE), emotional impact on parent 
(PTE), and time impact on parents (PTT). Additionally, a measure of limitations in family 
activities (FA) and family cohesion (FC) were made. Compared with children without 
ADHD, children with ADHD had "more parent-reported problems in terms of emotional 
behavioral role function, behavior, mental health, and self-esteem. In addition, the 
problems of children with ADHD had a significant impact on the parents' emotional health 
and parents' time to meet their own needs, and they interfered with family activities and 
f "1 h . , 24 arm y co es10n. 
Purpose of Systematic Review 
The potential effects of misdiagnosed and treated attention deficit hyperactivity 
disorder can have astounding consequences for the African-American youth population. 
Before steps can be taken to address the issues presented, the true prevalence rate of 
diagnosis and treatment must be understood. The purpose of this review is to examine the 
diagnostic and treatment prevalence of attention deficit hyperactivity disorder among 
African-American children and adolescents and compare the prevalence to Caucasian 




Eligibility criteria were established a priori to identify studies that would answer 
the questions: Is there a difference in the prevalence or incidence rate of diagnosis of 
attention deficit hyperactivity disorder in African-American children/adolescents compared 
to Caucasian children/adolescents? Is there a difference in the prevalence/ rates of 
treatment of attention deficit disorder in African-American children/adolescents compared 
to Caucasian children/adolescents? To answer both questions, criteria for studies were set 
to include cross-sectional studies, cohort, non-randomized clinical trials, and meta-analyses 
that compared African-Americans children and/or adolescents with Caucasian children 
and/or adolescents. Studies were considered eligible for review if they contained subjects 
aged 0-18 years with a diagnosis of ADD, ADD-H, or ADHD using the DSM-IV criteria, 
contained information regarding the diagnostic prevalence or prevalence of treatment for 
ADHD, and included results for both Caucasians and African-American 
children/adolescents in their results. See tables 1, 2, and 3 for exclusion criteria. Titles or 
abstracts of all potentially eligible studies were reviewed against these criteria. Possible or 
definitely eligible studies were retrieved and reviewed in detail by one reviewer. (Tables 1 
and 2). 
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Table 1. General Inclusion/Exclusion Criteria 
Category Inclusion Exclusion 
Database PubMed, Web of Science, Psychinfo Other databases 
Languages English Other languages 
Population Humans Animals 
Study Cross-sectional, cohort, non-randomized clinical RCTs, Letters, editorials 
Design trials, meta-analysis 
Table 2. Diagnostic and Treatment Prevalence Inclusion/Exclusion Criteria 
Category Inclusion Exclusion 
Publication Date 1994-present (year DSM-N criteria Before 1994 
published) 
Study Design Cross-sectional, cohort, non-RCT, meta- RCT's letters, 
analysis editorials 
Outcomes of Prevalence or incidence rate 
Interest 




Three different search engines were used to perform the literature review: Medline, 
Web of Science, and Psychlnfo. Medline utilized the following search terms: (African-
American* OR Blacks OR Afro American) AND (ADHD OR ADD OR attention deficit 
hyperactivity disorder, OR attention deficit disorder) AND (adolescent* OR teen* OR pre-
teen* OR children* OR child OR youngster* OR kid*). The search criteria for Web of 
Science included a combination of the following search terms: [TS=(ADHD OR attention 
deficit hyperactivity disorder OR ADD OR Attention deficit disorder) AND TS=(African 
American* OR Blacks OR Afro American*) AND TS=(Children* OR adolescent* OR 
teenager*), while the search string for Psychlnfo was similar: (ADHD OR ADD OR 
attention deficit hyperactivity disorder, OR attention deficit disorder) AND (African-
American* OR Blacks OR Afro American). References from relevant articles were hand-
searched to identify additional articles for inclusion in this review. 
Methodological Quality 
Quality of each study was assessed by one reviewer according to the "Quality 
Checklist for RCTs and Observational Studies" scale used in the AHRQ study of perinatal 
depression and based on a Methodological Quality checklist developed by Downs and 
Black, J Epidemiology and Community Health, 1998 (Evidence for review sheet). Items 
assessed included reporting (i.e. were hypothesis/aim/objective and outcomes of the study 
clearly described, etc.), external validity, bias, confounding, and power of the study to 
detect a significant difference in effect size for one or more outcome measures. According 
to this checklist, scores greater than or equal to 20 are considered good studies, scores 
15 
between 15 and 19 are considered fair, and scores of 14 and below are considered poor. 
(Appendix 1). 
Data Extraction 
For reviews concerning diagnostic prevalence, data were extracted for 6 areas of 
study: study characteristics (i.e. design), sample size, subject characteristics (age and sex), 
outcomes measured (details about prevalence characteristics), methodological quality, and 
main findings. Data were extracted similarly for reviews concerning treatment prevalence. 
All extracted data for outcome measurements were rechecked against the original articles 
at the time of data entry. 
Results 
Articles for Review 
The initial Medline, Web of Science, and Psychinfo searches returned 168, 209, 
and 44 articles respectively for a total of 421 articles. 335 articles were unique citations. 
After reviewing titles and abstracts, 31 articles were pulled for review and their 
bibliographies were examined for additional references. Seven additional relevant articles 
were found. Of these 25 articles, 12 studies met initial inclusion criteria (Fig 2). These 
studies were examined for quality using the Downs and Black methodological quality 
checklist and studies that rated fair or better were included iri the review. Thus, 11 studies 
met inclusion criteria and received detailed evaluation. 
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Figure 3. Flow diagram of systematic literature search and 
assessment. 
422 initial citations 
reviewed 
31 potentially relevant 
studies identified for retrieval 
of full text 
11 studies met inclusion 
criteria for diagnosis and/or 
treatment 
10 studies met quality 
criteria 
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87 duplicate citations excluded 
304 unique citations studies excluded on initial 
screen because abstracts did not address 
ADHD diagnosis and/or treatment in African 
Americans 
20 studies excluded 
- 18 did not compare rates of diagnosis 
and/or treatment between African Americans and 
Caucasians 
- 2 studies excluded because did not 
distinguish ADHD from other mood/anxiety disorders 
and only gave info for general psychotropic 
medications, not stimulants or ADHD meds 
specifically 
I study excluded because it rated 
-.. poor according to quality criteria 
Diagnostic Prevalence 
Four studies specifically compared prevalence of an ADHD diagnosis between 
African-Americans and Caucasians. Characteristics of these studies including study design. 
purpose. methods of obtaining ADHD information, and whether or not the prevalence of 
ADHD amongst different subgroups was a primary outcome are summarized in Table 3. 
The Downs and Black scores for methodological quality for these studies ranged from 18-
22. While tbe design of the studies hindered them from getting the maximum amount of 
quality points, other factors contributed to the studies getting fair to good ratings. Stevens 
et a! (2005) lost 4 points for failing to provide confidence intervals and actual probabilities 
for the main outcomes. Stevens et al (2004) lost 5 points for internal validity/bias. Points 
were deducted for failure to account for bias related to differential ascertainment of the 
outcome between ethnic groups and reliability, (e.g. no standard diagnostic method was 
mentioned in the study as used by the physician reporters), and failure to adjust for 
different lengths of follow-up of study participants (e.g. study investigators reported ethnic 
differences in tbe number of total visits but did not determine if total visits were due to the 
number of different patients or the average number of visits per patient.) Rowland eta! lost 
5 points for confounding, name! y failure to recruit participants over the same period of 
time and failing to account for factors that may affect the likelihood of being diagnosed 
and/or treated for ADHD (e.g., presence of health insurance or access to care.) Wasserman 
et allost 2 points for external validity (e.g., study participants were from a small group of 
children at high-risk for ADHD) and 3 points for confounding (e.g., investigators did not 
recruit participants over same period of time). All four studies used logistic regression to 
18 
determine the prevalence of ADHD amongst ethnic subgroups with respect to different 
variables such as age, gender, and health insurance. Because of the different sampling 
designs, formal statistical procedures and meta-analyses could not be performed. Results of 
the studies are summarized in Table 4. 
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Table 3. Studies Addressing Prevalence of ADHD in African-American children and Adolescents Compared to Caucasians 
Author; (Year) Study Purpose/Objectives Subjects/Inclusion Criteria Ethnic Subgroups ADHD Method of ADHD 
Design No.(%) Diagnosis Assessment Prevalence a 
Reporter (s) Primary 
Outcome? 
Stevens, J ., Cross- To identify socio- N-27,802 (#of White-American Parents or Medical Yes 
Harman, J., and sectional demographic disparities in observations) 13,727(67.4%t, head of Expenditure Panel 
Kelleher25 ; 2005 different stages of ADHD Children ages 3-18yrs old African-American household Surveys (MEPS) 
healthcare, including initial whose parents or head of 4981 (16.5%/, Household 
identification, follow-up household completed the Hispanic-American Component 
physician visits, and MEPS survey between 9094 (16.1%t 
psychotherapy visits 1997-2000 (+)-weighted 
percentage of 
observations 
Stevens J, Cross- To investigate ethnic and N-26,441 (#of White American Primary care ICD-9 codes and Yes 
Harman JS, sectional regional differences in observations) 16,406 (76% t physicians physician 
Kelleher KJ26; childhood mental heallh Children 3-18yrs old who African American recorded surveys 
2004 care in primary care, visited primary care 5074 (12%t of individual 
particularly with regards to providers in office-based Hispanic American patient encounters 
ADHD clinics or outpatient 4117 (12%)+ 
hospital clinics involved in 
the NAMCS and 
MHAMCS during 
Rowland A et Cross- To estimate the prevalence N-7333 eligible children, White Parent Two question Yes 
at27, 2002 sectional of medication treatment for 6099 (83% responded) 4437 (72.7%) survey 
ADHD among public Children in grades 1-5 who Black 
elementary school children attended Johnston County 1208 (19.8%) 
in grades 1 through 5 and to public elementary schools; Hispanic 
examine how prevalence Exclusions: Johnston 376 (6.2%) 
varies by grade, sex and County children of Other 
race/ethnicity elementary school age 78 (1.3%) 
auending private schools, 
receiving home schooling, 
attending middle schools, 
children w/ severe 
developmental disabilities 
placed in self-contained 
classrooms, and children 
auending regular classes 
w/special ed designations 
for autism, mental handicap 
(IQ<70), or severe health 
disabilities (i.e. traumatic 
head injury or childhood 
cancer) 
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Wasserman RC Prospective To determine the frequency N-22,059 entire study In sample Clinicians Clinicians Yes-general term 
et al28 ; 1999 cohort study of identification of population; 3934 in sample population determined AHP AHP (attentional 
atlentional-hyperactivity population of children with (N~3934i status (see next and hyperactivity 
problems (AHPs)by psychosocial problems) column) by means problems) was 
clinicians and to examine Children ages 4-15 being White- 81.8% of parent used instead of 
factors associated with seen for acute, chronic and African American interview, child ADHD 
clinician identification of health supervision visits in 7.4% interview, school 
AHPs in children practices of 401 pediatric Hispanic reports, 
recognized with and family practice 7.9% observation, 
psychosocial problems clinicians participating in Other standardized 
the Pediatric Research in 2.8% assessment tools, 
Office Seuings (PROS) and or previous 
Ambulatory Sentinel diagnosis by 
Practice Network (ASPN) another person 
systems 
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Table 4. Results for Studies Evaluating Diagnostic Prevalence of ADHD 
Study Quality Rating ADHD Prevalence OR P-value Confidence Conclusions Adjustment 
Author Interval for 
Confounders? 
Stevens et al. 21 Caucasian ~~ p<0.05 ~~ White Yes-health 
(2005) (Lost points for not American-5.1% American insurance, 
reporting estimates African American- children were region of 
of random variability 2.1% more likely to residence, 
(exact p-value or a Hispanic American- be diagnosed age 







vs. 2.1% and 
1.8%, 
Stevens et al 22 Caucasian ~~ ~~ No Yes-health 
(2004)26 American-2.7% significant insurance, 
African American- difference in region of 
1.9% 0.62 0.083 0.36~1.07 rates of residence, 
Hispanic American- ADHD age 
0.8% between 






Rowland et 18 (Lost points for Caucasian 1.0+ African- Yes--sex, 
a!. (2002) not reporting American-10.8% American grade, 
characteristics b/w African American- children were race/ethnicity 
eligible pop and 9.1% 0.9 0.19 0.7. 1..1 only slightly 
sample pop; Hispanic American- less likely 
inadequate 4.0% 0.4 <0.001 0.2, 0.6 than White 
adjustment for Other-3.9% 0.4 0.1, 1.2 children to be 
confounding diagnosed 
according to . withADHD 
insurance, family (adjusted 
income, other factors prevalence 
that affect access to ratio=0.90, 







Wasserman 21 (Lost points for Caucasian No Yes-parental 
RC etal28 ; generalizability, American-40.8%* significant marital status, 
(1.999) confounding) African American- 0.954 0.90 ~~ difference in age, parental 
3.7%* 1.062 0.86 ~~ rates of education 
HispanicAmerican- ADHD level, health 
3.5%* between insurance 
Caucasian status, region, 
American attentional 




+-AdJuSted for sex, grade and race/etbnic1ty 
*-Percentage of children \\lith attentionaVhyperactivity problems out of a sample of children \\lith psychosocial problems 
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Stevens et al. (2005i5 used data from the 1997-2000 Medical Expenditure Panel 
Survey (MEPS), a nationally representative survey of U.S. civilians, to determine if 
ADHD diagnoses, stimulant usage, and number of health care visits varied by age, 
race/ethnicity, region, and type of insurance. The authors used weighted percentages to 
determine the number of children diagnosed with ADHD according to age, ethnicity, 
region and type of insurance. They found White American children were more likely to be 
diagnosed with ADHD compared to African-American youths (5.1% vs. 2.1% p<0.05). 
They also found regional differences in ADHD diagnosis; children in the Northeast and 
West were less likely to be diagnosed than children in the South (3.6% and 2.9% vs. 4.8% 
respectively, p<0.05). Children who lived in the Midwest were more likely to be diagnosed 
than children in the West (4.3% vs. 2.9% respectively, p<0.05). 
In a study published a year earlier by the same group, Stevens et al (2004i6 
examined data from the 1995-2000 National Ambulatory Medical Care Survey (NAMCS) 
and the National Hospital Ambulatory Medical Care Survey (NHAMCS) to evaluate ethnic 
and regional differences in primary care visits for children with respect to the frequency of 
ADHD diagnosis, stimulant prescriptions, and other mental health diagnoses. Both surveys 
sampled nationally representative groups of visits to primary care physicians. Of the 
26,441 visits, 902 of them involved a child with a diagnosis of ADHD. The authors found 
that the odds of an African American child being diagnosed with ADHD was 0.62 
compared to White children but this was not statistically significant (p=0.83, 95% CI 0.36-
1.07). Their study also found that with regards to type of health insurance, an ADHD 
diagnosis was more likely to be recorded during visits by children on Medicaid than for 
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visits by children with other types of insurance (OR-2.23, p-value=0.011, 95% CI 1.21-
4.11) 
Rowland eta! (2002i7 sought to determine the prevalence of medication treatment 
for ADHD among elementary school children in Johnston County, North Carolina during 
1997-1998 and to see how the prevalence varied by grade, sex and race/ethnicity. Parents 
from 17 elementary schools in Johnston County received a 2-item questionnaire containing 
questions of whether a doctor or psychologist had diagnosed their child with ADHD and if 
their child was currently taking medication prescribed by a clinician to help with 
symptoms of ADHD. The authors found that African-American children were only slightly 
less likely than White children to have been diagnosed with ADHD (adjusted prevalence 
ratio=0.9, p<0.001, 95% CI 2.6, 3.7). Gender and age differences in ADHD diagnosis 
emerged as significant. 
Wasserman et al (1999i8 recruited physicians from the Pediatric Research 
in Office Settings (PROS) and Ambulatory Sentinel Practice Network (ASPN) groups to 
enroll 70 consecutive children ages 4 to 15 years who presented for non-emergency care 
in their clinics. The authors compared children with newly-diagnosed attentional and 
hyperactivity problems (AHPs) to those with other psychosocial problems using logistic 
regression analysis. They found no significant difference between African-American 
children being diagnosed with AHPs vs. White American children (OR=0.954, p=0.90). 
The authors also found differences in gender and age in diagnosis of ADHD. 
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Treatment Prevalence 
Nine studies specifically addressed treatment rates for ADHD among different 
ethnic subgroups. Characteristics of these studies are included in Table 5. The Downs and 
Black scores for methodological quality ranged from 15-24; the average score was twenty-
one. Similar to the diagnostic studies, the studies were either cross-sectional or 
longitudinal designs which precluded them from scoring perfect scores. Also other factors 
contributed. Safer et al and Rowland eta! both had quality scores below average. Safer et 
al's study, which scored the lowest, lost significant points for reporting, and internal 
validity for bias and confounding. Safer failed to provide estimates of random variability 
such as confidence intervals as well as actual probability values for the main outcomes. 
Similar to the Stevens et al. 2004 study, the authors did not account for biases related to 
differential ascertainment of the outcomes between groups (e.g. several different methods 
of diagnosis were used by the physician reporters and were not standardized) thus making 
the validity and reliability of the results questionable. Safer et al also did not factor 
confounders such as presence or absence of health insurance or other socioeconomic 
factors in the analysis. Rowland et allost 5 points for confounding as previously described. 
All nine studies also used logistic regression to determine treatment prevalence among 
different ethnic groups. Similar to the diagnostic studies, due to the difference in sampling 
designs, formal statistical procedures and meta-analyses could not be performed. Results of 
the studies are summarized in Table 6. 
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Table 5. Characteristics of Studies Addressing Treatment Rate of ADHD in African-American children and Adolescents 
Comuared to C 
----------
Author; Study Design Purpose/Objectives Subjects/Inclusion Ctiteria Ethnic Subgroups ADHD Method of Assessment ADHD 
(Year) No.(%) Treatment Treatment 
Reporter (s) Rates a 
Primary 
Outcome? 
Zito el a! Cross- To identify 1) the 1991 prevalence Children ages 5-14 who received N-99,217 Medicaid Person-based data set Yes 
(1998)'" sectional of psychotropic medication Medicaid in Maryland and were Caucasian 38,349 prescription created from Medicaid 
(retrospective prescribed to African-American seen in ambulatory settings by (38.7%) reimbursement prescription reimbursement 
analysis) and Caucasian Medicaid recipient physicians during the 1991 fiscal African-American claims and claims and enrollment 'files 
youths ages 5-14, 2) the race- year 60,868 enrollment 'files 
specific prevalence ration for the (61.3%) 
most frequently prescribed 
psychotropic medication classes, 
and 3) the race and regional 
distribution of psychotropic and 
non-psychotropic medication 
classes 
Bussing Prospective To describe the use and Children were eligible if they were N-220 Parents, school Surveys (Norbeck Social Yes 
etal cohort study persistence of ADHD medication enrolled in a particular North representing an database and support questionnaire, 
(2005)30 treatment and of relevant school Central Florida public school overall response disciplinary Caregiver Strain 
services during a 2 year period, to district during the 1998-99 rateof17%) referrals questionnaire, Diagnostic 
examine how these outcomes vary academic year, lived in a household Caucasian Interview Schedule for 
by gender and race; and to explore with a telephone, were not 152 (69.1%) Children 4lh edition (DISC-
the roles of gender and race as receiving special education for African-American IV), and the Child and 
independent predictors of mental retardation or autism, and 69 (30.9%) Adolescent Services 
medication treatment and school were from Caucasian or African- Assessment) 
services. American backgrounds. Initial No. 
eligible children=l2,009 
Study participants were derived 
through a gender-stratified random 
design from the longitudinal study 
to produce a representative sample 
of children at high-risk for ADHD 
(N=l276) 
Olfson et Cross- To examine national trends in the Children ages 3-18 whose parents 1987 survey Parents or head Medical Expenditure Panel Yes 
a! sectional outpatient treatment of ADHD or head of households completed (weighted of household Surveys (MEPS) 
(2003)31 the household components of the samples) Household component 
1987 and/or 1997 Medical White American given during four personal 
Expenditure Panel Surveys (70%) interviews in the 1987 
No. from 1987 survey=8,367 African American survey and three personal 

















LeFever Cross To determine the extent of Public school students enrolled in Breakdown for School nurses School nurses recorded No 
et al sectional medication use for ADHD in grades 2 through 5 in two sample not health-related information 
(1999)32 Southeastem Virginia Southeastern Virginia cities during available for all students receiving 
the 1995-1996 school year. ADHD medication in 
Exclusions: students in non-graded school which was merged 
special education placements with the school districts 
(designed for children with severe comprehensive student 
intellectual impairments) database containing 
N=5,767 in City A and N=23,967 demographic information. 
in City B. A subset of this new 
A subset of this sample diagnosed database was made 
with ADHD was used to determine available to the principal 
rate of treatment. investigator 
City A subset N=467; City B subset 
N-2,199 
FoxM, Cross- To perform a population-based Youths less than 20 years of age N-5574 Kansas Medicaid Person-based data set Yes 
Foster sectional examination of psychotropic drug enrolled in Kansas Medicaid and Caucasian prescription created from Medicaid 
CH. prescription trends among low- receiving psychotropic drug Americans-81 I% reimbursement prescription reimbursement 
(1999}'5 income youths with respect to age, prescriptions in 1995 African claims and claims and enrollment files 
ethnicity, gender, and region of Americans-12.5% enrollment files 
residence Hispanics-3.5% 
Safer DJ Cross- To determine the prevalence of Children enrolled in Maryland Caucasian School nurses School nurses collected Yes 
and sectional medication administered to public schools and receiving American-55.9% health-related and 
Malever Maryland public school students ADHD medication treatment in African American- demographic information 
M for the treatment of ADHD Aprill998;N=23,771 36.1% on all students receiving 
(2000)" Hispanic-3.72% ADHD medication during 
Asian-3.97% school hours and recorded 
Native American- it on a survey form 
0.32% 
Stevens, Cross- To identify socio-demographic N 27,802 (#of observations) White-American Parents or head Medical Expenditure Panel Yes 
et al sectional disparities in different stages of Children ages 3-18yrs old whose 13,727(67.4%)+, of household Surveys (MEPS) 
(2005)" ADHD healthcare, including parents or head of household African-American Household Component 
initial identification, follow-up completed the MEPS survey 4981 (16.5%)\ 
physician visits, and between 1997-2000 Hispanic-
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Stevens Cross- To investigate ethnic and regional N-26,441 (#of observations) White American Primary care ICD-9 codes and physician Yes 
et al sectional differences in childhood mental Children 3-18yrs old who visited 16,406 (76%t physicians recorded surveys of 
(2004)" health care in primary care, primary care providers in office- African American individual patient 
particularly with regards to based clinics or outpatient hospital 5074 (12%t encounters 
ADHD clinics involved in the NAMCS and Hispanic 
MHAMCS during American 
4117 (12%/ 
Rowland Cross- To estimate the prevalence of N-7333 eligible children, 6099 White Parent Two question survey Yes 
A et ae7, sectional medication treatment for ADHD (83% responded) 4437 (72.7%) 
2002 among public elementary school Children in grades 1-5 who Black 
children in grades 1 through 5 and attended Johnston County public 1208 (19.8%) 
to examine how prevalence varies elementary schools; Hispanic 
by grade, sex and race/ethnicity Exclusions: Johnston County 376 (6.2%) 
children of elementary school age Other 
auending private schools, receiving 78(1.3%) 
home schooling, attending middle 
schools, children w/ severe 
developmental disabilities placed in 
self-contained classrooms, and 
children attending regular classes 
w/special ed designations for 
autism, mental handicap (IQ<70), 
or severe heallh disabilities (i.e. 
traumatic head injury or childhood 
cancer) 
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Table 6R . I esu ts o fS tudies Evaluatilll;! Treatment p I reva ence t ADHD or 
Study Quality ADHD OR P-value Confidence Conclusions Adjustment for 
Author Rating Treatment Interval Confounders? 
Prevalence 
Zito et al 23 (Lost Caucasian 2.5 -- Caucasians were Yes-region, 
(1998)" points for American- 2.5times more period of 
not 3.76%+ likely to receive a enrollment in 
reporting African 1.0 -- -- stimulant Medicaid 
American- medication than 
1.49%+ African-
Americans; p-
values and CI 
given for 
psychotropic 
medications as a 
class, though not 
specifically for 
stimulants 
Bussing et 23 Caucasian African-American Yes-adjusted 
a! (2005i0 American- children with for 
NIR' ADHD were 0.91 predisposing, 
African 0.91, 3.46' --, <0.01 0.36-2.34; times as likely to need, and 
American- 1.31-9.09 beonADHD enabling 
NIR' medication variables (i.e. 
compared to age, economic 
Caucasian status, parental 
children with characteristics, 
ADHD but this impairment 






3.46 times more 
likely to receive 
relevant school 
services for 
ADHD which was 
statistically 
significant 
Olfson eta! 22 Caucasian White children Yes- Age, 
(2003i1 Americans- -- -- were more than gender, family 
1.1 %, 4.4%* twice as likely as income, health 
African- African-American insurance 
Americans- children to receive 
0.3%, 1.7%* treatment(!.!% 
Hispanic- vs. 0.3% in 1987, 
0.3%, 1.5%* respectively and 
Other-0.2%, 4.4% vsl.7% in 
0.8%* 1997, 
respectively). 
LeFever et 24 Caucasian City A- White students Yes-age for 
a1 (1999)" Americans- Caucasian were grade, sex 
NIR Am-2.1 P<O.OOl 1.74, 2.54 approximately 
African City B- twice as likely as 
Americans- Caucasian P<0.001 2.03, 2.41 Black students to 






FoxM, 21 Caucasian 1.20+ N/R 1.03,1.40 African Yes-age, 
Foster CH. Americans- Americans were region, gender 
(1999)" African less likely than 
Americans- 0.81+ 0.68, 0.97 Caucasian 
Hispanic- 1.05+ 0.70, 1.43 Americans to 
Other- 0.90+ 0.82, 0.99 receive a 
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Rowland A 18 Caucasian 








--Refers specrfically to shmulant treatment 
#-Ratio of children receiving relevant school services for ADHD 
$-NIR=not reported 
*Rate of receiving ADHD treatment in 1987 and 1997 










NIR African Yes-grade 
Americans were 5 
1h times less likely 






NIR White American Yes-health 
children with insurance, 
ADHD were more region of 








There was no Yes-health 
statistically insurance, 
-- significant region of 
difference in the residence, age 
likelihood of 










African American Yes-sex, grade, 
elementary school race/ethnicity 
-- students in 
Johnston County, 
NC were 0.7 
0.5, 0.8 times as likely to 
be receiving 









Three of the studies that reported treatment prevalence were also used in the 
diagnostic prevalence analysis and are described in detail in the previous section. Stevens 
eta! (2005) found Caucasian American children with ADHD were more likely to receive at 
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least one stimulant prescription compared to African-Americans with ADHD (76.5% vs. 
60.5%, p<0.05). Interestingly, Stevens eta! (2005) also found that children with ADHD 
who had private insurance were more likely than children on public insurance or who had 
no insurance to receive at least one stimulant prescription. In the 2004 Stevens eta! study, 
the authors found no ethnic differences in the likelihood of receiving a stimulant or non-
stimulant if a child had been diagnosed with ADHD (p>0.10) but did find a difference in 
stimulant prescriptions relative to insurance status, identical to Stevens 2005 study. 
Rowland eta! found that AD liD-diagnosed African American children were 0.7 times as 
likely as Whites to be taking ADHD medication (p<0.001, 95% CI 0.6, 0.9). 
Zito et al (1998f9 and Fox eta! (1999)35 both used Medicaid data to evaluate 
variations in psychotropic drug use in children. Zito used Maryland Medicaid data from 
the 1991 fiscal year to examine the prevalence of psychotropic medications, including 
stimulants, prescribed to African-American and Caucasian Medicaid recipient youths ages 
5-14 while Fox looked at 1995 Medicaid data from Kansas and one other Midwestern state 
for children under 20. With regard to stimulant use, Zito et a! found that Caucasian youths 
with Medicaid insurance aged 5-14 years were 2.5 times more likely to use stimulants than 
African-American youths (no p-value or confidence intervals were reported for this 
measurement). Methylphenidate was the most commonly prescribed stimulant, accounting 
for 89.6% of stimulant use. Zito eta! examined period of enrollment as a possible factor in 
the decreased amount of psychotropic medication use amongst African-American youth 
but found that "continuous enrollment favored African-Americans (55% vs. 46% for 
Caucasians)." Also, though not looking at stimulants specifically, the authors found that 
irrespective of region psychotropic medications were prescribed more often to Caucasian 
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youth compared to African-American youth. They postulated relatively less psychiatric 
follow-up care and cultural differences including family attitude towards the mental health 
system as possible reasons for this discrepancy. Fox found African American children 
were less likely to receive stimulant medication than Caucasian children (OR 0.86 vs. 
1.23). No tests of statistical significance were given in comparing these odds ratios. 
Bussing eta! (2005)30 conducted a prospective cohort study using a gender-
stratified random design from a longitudinal study of elementary school students from a 
North Central Florida school district to produce a representative sample of children at 
high-risk for ADHD (N=1276). The authors found no difference in rates of medication 
treatment amongst African-American and Caucasian youth though they did note that 
African-American children utilized more special school services for ADHD. 
Similar to the Stevens (2005)25 study, Olfson et a! (2003)31 used data from the 
Medical Expenditure Panel Survey (MEPS) to examine national trends in the outpatient 
treatment of ADHD and how it differs across race, gender, health insurance status, and 
family income. The authors examined results from the 1987 and 1997 household 
component of the MEPS and combined information from the two to examine relationships 
between the two surveys with regards to stimulant prescriptions, psychotherapy visits, and 
treatment visits. Samples were weighted to adjust for non-responseas well as to provide 
unbiased national estimates. They found that White children were more than twice as likely 
as African-American children to receive treatment (1.1% vs. 0.3%, respectively for 1987 
survey, 4.4% vs. 1.7% respectively for the 1997 survey). Odds ratios, a p-value and 95% 
confidence interval were not reported for this particular result. Although there was an 
overall observed increase in ADHD treatment from 1987 to 1997, African-American still 
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lagged behind Caucasian Americans in rates of treatment, even after controlling for 
economic factors such as family income and health insurance status. The authors 
concluded that cultural factors may play a role in this disparity. 
LeFever eta! (1999) 32 and Safer et al (2000) both assessed the prevalence of 
ADHD medication use amongst students in public schools. LeFever examined elementary 
school students in two school districts in Southeastern Virginia while Safer looked at use 
amongst all grade levels in all Maryland public schools. LeFever found White students 
were approximately twice as likely as Black students to receive ADHD medication in both 
cities (City A OR 2.1, p<0.001, 95% CI 1.74, 2.54; City B OR 2.2, p<0.001, 95% CI 2.03, 
2.41). Safer found the White/Black methylphenidate prevalence ratio to range from 2.0:1 
in elementary school, 2.6:1 in middle school, and 5.2:1 in high school. No estimates of 
random variability or statistical significance were reported. 
Overall, three of the four (75%) of the articles examining diagnostic prevalence 
demonstrated there was no significant difference in the likelihood of being diagnosed with 
ADHD between Caucasian American and African-Americans children. Of the articles 
examining treatment prevalence, seven of the nine (71.4%) articles demonstrated African-
Americans were less likely than Caucasian Americans to receive ADHD medications. 
While the heterogeneity of the studies precludes firm conclusions, the trend seems to 
reveal that African American youth are diagnosed with ADHD at approximately equal 




The objective of this review was to identify studies that compared ADHD diagnosis 
and treatment prevalence of African Americans with Caucasian Americans to determine if 
any disparities exist. Overall, despite the relatively low quality of the evidence and the 
inability to group study effects together in a meta-analyses, it appears that disparities do 
exist in regards to ADHD treatment but not in diagnosis. In addition, other disparities in 
ADHD were noted. Several studies reported regional and health insurance factors that 
contributed to differences in both diagnosis and treatment of ADHD. While many of the 
studies report controlling for these factors in their logistic regression models, examining 
whether there is a specific interaction between the race/ethnicity and these factors certainly 
deserves further investigation. 
There are several limitations to this review. Primarily, the studies themselves were 
not without methodological flaws. The majority of the studies were cross-sectional or 
cohort designs which lends themselves to multiple biases. First, selection bias may have 
been present in the majority of the studies. The self-selected nature of many of the studies 
creates the potential for participants to be significantly different than non-participants 
which could have varied significantly across different ethnic subgroups. The majority of 
studies lacked adequate descriptions of techniques for adjusting for baseline group 
differences; in fact only 1 (Wasserman) out of the 10 (10%) studies specifically reported 
these differences. Secondly, 4 out of the 10 (40%) studies used parental surveys as a 
method of determining ADHD diagnosis or medication treatment and did not use other 
measures of validating their responses. Thus report/recall bias may have potentially 
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affected the results. Of the two studies that used clinician reports for diagnosis, one study 
reported clinicians used a variety of tools to diagnose children with 
attentional/hyperactivity problems. Wasserman eta!. reported the DSM-IV criteria were 
only used to diagnose 38.3% of subjects. This could result in significant inter-rater 
variability in diagnosis, which decreases the validity of this study's results. Confounding 
could have played a role in the interpretation of results if all extraneous factors were not 
adjusted for in the analysis. Access to care and socioeconomic factors have been shown to 
be a determinant of whether children are recognized and treated for ADHD. 18 Seven of the 
10 (70%) studies factored in presence of health insurance in their analysis while only 2 of 
the 10 (20%) examined family income as potential confounders. Statistical analysis varied 
amongst the studies. Four of the 8 treatment studies and one of the diagnostic studies did 
not report specific estimates of random variability which brings into question the reliability 
of the reported values and subsequent conclusions. Finally, the ability to generalize the 
results to all children was severely limited due to the widely different populations in the 
various studies. One study used children at high-risk for ADHD, two considered only 
children receiving Medicaid, three considered children enrolled in public schools, while 
only three reported using nationally representative data. 
In addition to limitations within specific studies, this review has its own limitations. 
Even though three large search engines were used with rather broad search terms, there 
were only 10 studies identified that ultimately met inclusion and quality criteria. This 
could represent a paucity of published studies that specifically compare African Americans 
with Caucasian Americans with respect to ADHD diagnosis and treatment or a flaw in the 
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initial search strategy. Quality for each study was assessed by only one reviewer, whereas 
most systematic reviews use two or more to make the quality assessment more reliable. 
In addition to the need for higher quality, population-based studies that examine the 
disparate relationship between ADHD recognition and treatment in African American 
youth, further research should be dedicated to examining the factors that affect ADHD 
treatment rates in this subgroup. Bussing et al11 examined parental explanatory models of 
ADHD to determine if differential understanding of ADHD across ethnic subgroups 
contributed to the cultural variations in parental help seeking for children with ADHD. 
Interestingly, with regards to ADHD treatment African American parents were more likely 
than Caucasian parents to report they did not know what type of treatment their child 
should receive (medication vs. psychosocial interventions vs. school interventions vs. self-
care) and were less likely than Caucasian parents to request medication treatment or school 
interventions. In a similar study examining parental help-seeking for ADHD symptoms by 
Bussing et al37 published seven years later, the authors found African American parents 
were more likely than Caucasian parents to seek help from family members and less likely 
from healthcare professionals. Since more often than not parents play a major role in 
whether their child is treated for various conditions, perhaps parental-level factors are 
contributing to the disparity seen in ADHD treatment. 
In a study conducted by Arnold et al38 examining the responses of different ethnic 
subgroups to ADHD treatment, the authors found African American children responded 
equally to stimulant treatment as Caucasian children but benefited more than Caucasians 
with a multimodal treatment strategy including medication and behavioral therapy. This 
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may have implications for overall treatment effectiveness of ADHD in African American 
children. 
In summary, based on the current literature, it appears that African-American youth 
are equally diagnosed with ADHD but under-treated with respect to medication use. 
Future directions for research include producing additional high-quality population-based 
studies that examine disparities in ADHD diagnosis and treatment amongst ethnic 
subpopulations and exploring potential interactions with socioeconomic, regional and 
parental factors that may impact rates of ADHD treatmenton African American youth. 
Furthermore, the development of culturally-sensitive messages in recognizing the 
symptoms and treatment options for ADHD may benefit the minority community and 
reduce the apparent disparate relationship in ADHD treatment. 
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Appendix 1. Methodological Quality Worksheet 
Quality Checklist for RCTs and Observational Studies 
(used in the AHRQ study of perinatal depression and based on a Methodological Quality 
checklistdeveloped by Downs and Black, J Epidemiology and Community Health, 1998). 
Reviewer's initials ____ _ 
First Author ____ _ Journal: _____________ _ 
Year published __ 
Reporting 
1 Is the hypothesis/aim/objective of the study clearly 
described? 
2. Is the under! ying theory described? 
3. Are the main outcomes to be measured clearly 
described in the Introduction or Methods section? 
4. Are the characteristics of the study population 
included in the study clearly described? 
5. Are the interventions under-study clearly described? 
6. Was exposure to the intervention measured? 
7 Are the distributions of principal confounders in 
each group of study participants to be compared 
clearly described? 
8. Are the main findings of the study clearly described? 
9. Does the study provide estimates of the random 
variability (e.g., standard error, standard deviation, 
confidence intervals, inter-quartile range) in the data 
for the main outcomes? 
10. Have all important adverse events/negative outcomes 























11. Have the characteristics of study participants lost to 
follow up been described? 
12 
Have aetna! probability values been reported (e.g., 
0.035 rather than <0.05) for the main outcomes 
except where the probability value is less than 0.001? 
1 0 
1 0 
Total Reporting score: __ 
Yes No U/D 
External Validity 
13 Were the study participants asked to participate 1 
representative of the entire population from which 
they were recruited? 
14. Were study participants who agreed to participate 1 
representative of the entire population from which 
they were recruited? 
15. Were the staff, places, and facilities where the study 1 
participants received the intervention representative of 
the intervention the majority of subjects receive? 






Total External Validity Score: 
Internal Validity -Bias Yes No U/D 
Answer this 17 and 18 only if this was a 
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randomized controlled trial: 
17. Was an attempt made to blind study participants to tbe 1 0 0 
intervention they received? 
18. Was an attempt made to blind those measuring the 1 0 0 
main outcomes of tbe intervention? 
Answer alternative 17 and 18 if this was not a 
randomized controlled trial: 
17. Were appropriate methods used to adjust for the 1 0 0 
differences between groups witb and without tbe 
intervention (to control for selection bias)? 
18. Were appropriate methods used to account for any 1 0 0 
biases related to differential ascertainment of the 
outcome in groups with or without tbe intervention? 
19. If any of the results of the study were based on "data 1 0 0 
dredging," was this made clear? 
20. In trials and cohort studies, do tbe analyses adjust for 1 0 0 
different lengtbs of follow-up of study participants, or 
in case-control studies, is the time period between the 
intervention and outcome tbe same for cases and 
controls? 
21. Were the statistical tests used to assess the main 1 0 0 
outcomes appropriate? 
22. Was compliance witb tbe intervention reliable? 1 0 0 
23. Were tbe main outcome measures used accurate (valid 1 0 0 
and reliable)? 
Total Bias Score: 
Internal Validity - Confounding 
24. Were the study participants in the different 
intervention groups (trials and cohort studies) or were 
tbe cases and controls (case-control studies) recruited 
40 
Yes No U/D 
1 0 0 
from the same population? 
25. Were study participants in the different intervention 1 0 0 
groups (trials and cohort studies) or were the cases 
and controls (case-control studies) recruited over the 
same period of time? 
26. Were study participants randomized to intervention 1 0 0 
groups? 
27. Answer this Q.27, if randomization occurred: was 1 0 0 
the randomized intervention assignment concealed 
from both study participants and intervention staff 
until recruitment was complete and irrecoverable? 
27. Answer this Q.27, if randomization did not occnr: 1 0 0 
were study participants in the research or evaluation, 
unaware of the study hypotheses? 
28. Was there adequate adjustment for confounding in the 1 0 0 
analyses from which the main findings were drawn? 
29. Were losses of study participants to follow-up taken 1 0 0 
into account? 
Total Confounding Score: 
Power 
30. Did the study mention having conducted a power analysis to determine the sample size needed 
to detect a significant difference in effect size for one or more outcome measures? 
No 0 
Yes, one measure 1 
Yes, two or more measures 2 
Total Power Score 
41 
Total Quality Score: __ _ 
(sum of all domain scores) 
*P = Partially 
U/D =Unable to Detennine 
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